Health Care Services

Nano-X Imaging

Tencent

Financial Analysis

00700

AIMID

GOOG

GOOGL

NNOX

000656

TCTZF

TCEHY

80700

GGLS

GGLL

NANO

HTCD

SBCWW

<p>After the Hong Kong stock market closed on November 13, Beijing time, <span class="security-tag" type="security-tag" counter_id="ST/HK/700" name="TENCENT" trend="">$TENCENT(00700.HK)</span> released its third-quarter 2025 results. Overall, while there were not many surprises compared to expectations, stability remains the key theme, with no significant weaknesses in the three major business lines. Since the beginning of this year, Tencent has entered a new investment cycle, yet traces of the management's refined operations and effective capital allocation can still be observed. Specifically: 1. Gaming remains the standout: Tencent Games maintained high growth of 23% in the third quarter, driven by the product cycle. Overseas, under the leadership of Supercell's 'Clash Royale,' it continued to surge (with favorable exchange rate contributions)...</p>

TENCENT

Meta Platforms

AIM IMMUNOTECH INC

AIM ImmunoTech

Alphabet - C

Alphabet

JINKE PROPERTY

SBC Medical

Tencent Holdings Limited

TENCENT-R

Direxion Daily Googl Bear 1x Shares

Direxion Daily GOOGL Bull 2X Shares

Pro Ultra 7-10Yrs

Nanoco Group PLC

Tencent HK SDR 10to1

SBC MEDICAL GROUP HOLDINGS INCRPRTD C/WTS 17/09/2029 (TO PUR COM)

Tencent: Not playing heartbeats with Meta, just seeking stable happiness

Nanox.AI's Spinal Assessment Technology Recommended for Early Value Assessment by NHS

Nano-X Imaging released FY2025 Q3 earnings on November 20 Pre-Market EST, actual revenue USD 3.447 M (forecast USD 3.505 M), actual EPS USD -0.2127 (forecast USD -0.2133)

Nano-X Imaging released FY2025 9 Months earnings on November 20 Pre-Market EST, actual revenue USD 9.302 M, actual EPS USD -0.6501

Nano-X Imaging Ltd Acquires VasoHealthcare IT Inc to Enhance AI-Driven Medical Imaging Technology

Nano-X Imaging to release FY2025 Q3 earnings on November 20 Pre-Market EST, forecast revenue USD 3.505 M, EPS USD -0.2133

Nano-X Imaging released FY2025 Q2 earnings on August 12 Pre-Market EST, actual revenue USD 3.04 M (forecast USD 3.2 M), actual EPS USD -0.2303 (forecast USD -0.19)

Nano-X Imaging released FY2025 Semi-Annual Earnings on August 12 Pre-Market EST, with actual revenue of USD 5.855 M and EPS of USD -0.4377

Nano-X Imaging to Release FY2025 Q2 Earnings on August 12 Pre-Market EST, Forecast Revenue USD 3.2 M, EPS USD -0.19

Nano-X and Kaiser University Partner to Promote 3D Medical Imaging Education

D. Boral Capital Maintains Buy Rating on Nano X Imaging

Nanox AI Obtains EU Medical Device CE Certification

Nano-X Imaging Ltd reports Q1 EPS loss of 21 cents, revenue missed expectations

Nano-X Imaging released FY2025 Q1 earnings on May 22 Pre-Market EST, actual revenue USD 2.815 M (forecast USD 3.977 M), actual EPS USD -0.207 (forecast USD -0.1925)

Nano X Imaging to Report Earnings on May 22, 2025

Nano-X Imaging Ltd to Post 19 Cent Loss Per Share, Revenue Up 56%

Nano-X Imaging to release FY2025 Q1 earnings on May 22, 2025, pre-market EST; forecast revenue USD 3.977 M, EPS USD -0.1925

Nanox Imaging Ltd Obtains FDA 510(k) Certification

Boral Capital Reaffirms Buy Rating on Nano-X Imaging with Target Price of $15

Nano-X Imaging (NNOX) Holds Q4 FY 2024 Earnings Call on March 31, 2025, Discussing Financial Results and Operational Updates

Nano-X Imaging Ltd Reports Quarterly Financial Performance, Losses Widen, Revenue Below Expectations

Nano-X Imaging(NNOX.US)